(R)-2-(((1-(3-(2-Cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)amino)methyl)benzonitrile
- CAS
- 2749424-28-8
- Formula
- C26H26N6O2
- MW
- 454.5 g/mol
VQ-020766
Impurity reference standards
Alogliptin impurities & reference standards
Characterised Alogliptin impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
57reference materials
3nitrosamine impurities
2isotope-labelled
COAHPLC · NMR · MS on request
(R)-2-((6-(3-((3-(2-Cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
- CAS
- 1268836-55-0
- Formula
- C31H30N8O4
- MW
- 578.6 g/mol
VQ-020767
(R)-2-((6-(3-(1,3-Dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
- CAS
- 1430222-09-5
- Formula
- C26H23N5O4
- MW
- 469.5 g/mol
VQ-043037
(R)-2-((6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzamide
- CAS
- 1820685-30-0
- Formula
- C18H23N5O3
- MW
- 357.4 g/mol
VQ-021505
(R)-2-((6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzoic Acid
- CAS
- 2748587-69-9
- Formula
- C18H22N4O4
- MW
- 358.4 g/mol
VQ-024204
(R)-3-((6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
- CAS
- 1339955-49-5
- Formula
- C18H21N5O2
- MW
- 339.4 g/mol
VQ-021509
(R)-4-((6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile Benzoate
- CAS
- 1638544-63-4
- Formula
- C25H27N5O4
- MW
- 461.5 g/mol
VQ-029071
(R)-5-Methyl-2-(piperidin-3-yl)isoindoline-1,3-dione
- CAS
- 1573118-32-7
- Formula
- C14H16N2O2
- MW
- 244.29 g/mol
VQ-035320
(R)-N-(1-(3-(2-Cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)acetamide
- CAS
- 1108731-49-2
- Formula
- C20H23N5O3
- MW
- 381.4 g/mol
VQ-028803
(S)-2-((6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
- CAS
- 1108732-05-3
- Formula
- C18H21N5O2
- MW
- 339.4 g/mol
VQ-028908
(S)-6-(3-Aminopiperidin-1-yl)-3-methylpyrimidine-2,4(1H,3H)-dione
- CAS
- 2276316-91-5
- Formula
- C10H16N4O2
- MW
- 224.26 g/mol
VQ-028804
(S)-N-(1-(3-(2-Cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)benzamide
- CAS
- 1618644-32-8
- Formula
- C25H25N5O3
- MW
- 443.5 g/mol
VQ-024207
2-((6-Chloro-3-ethyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
- CAS
- 1430222-06-2
- Formula
- C14H12ClN3O2
- MW
- 289.71 g/mol
VQ-024064
![2-[[3,4-Dihydro-3-methyl-2,4-dioxo-6-[(3R)-3-piperidinylamino]-1(2H)-pyrimidinyl]methyl]-benzonitrile chemical structure](/media/structures/CJUQMOXPZCAFBI-OAHLLOKOSA-N.svg)
2-[[3,4-Dihydro-3-methyl-2,4-dioxo-6-[(3R)-3-piperidinylamino]-1(2H)-pyrimidinyl]methyl]-benzonitrile
- CAS
- 2089611-85-6
- Formula
- C18H21N5O2
- MW
- 339.4 g/mol
VQ-020765
2,2'-((6-Chloro-2,4-dioxopyrimidine-1,3(2H,4H)-diyl)bis(methylene))dibenzonitrile
- CAS
- 1618644-29-3
- Formula
- C20H13ClN4O2
- MW
- 376.8 g/mol
VQ-024205
6-(3-Aminopiperidin-1-yl)-3-methylpyrimidine-2,4(1H,3H)-dione
- CAS
- 1338677-76-1
- Formula
- C10H16N4O2
- MW
- 224.26 g/mol
VQ-024209
![6-Chloro-1',3-dimethyl-2H-[1,4'-bipyrimidine]-2,2',4,6'(1'H,3H,3'H)-tetraone chemical structure](/media/structures/WEPMHUKDJRWGOY-UHFFFAOYSA-N.svg)
6-Chloro-1',3-dimethyl-2H-[1,4'-bipyrimidine]-2,2',4,6'(1'H,3H,3'H)-tetraone
- CAS
- 2468009-93-8
- Formula
- C10H9ClN4O4
- MW
- 284.65 g/mol
VQ-034778
Alogliptin N-Methyl Dihydropyrimidinyl Benzonitrile
- CAS
- 2749428-42-8
- Formula
- C13H10ClN3O2
- MW
- 275.7 g/mol
VQ-044968
Tert-Butyl (R)-(1-(2-cyanobenzyl)piperidin-3-yl)carbamate
- CAS
- 1353254-15-5
- Formula
- C18H25N3O2
- MW
- 315.4 g/mol
VQ-029070
FAQs — Alogliptin impurities
Which Alogliptin impurities do you supply?
We list 57 Alogliptin-related reference materials, including process impurities, degradation products, nitrosamine impurities, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Alogliptin impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Alogliptin impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Alogliptin impurity standards
We reply within one business day with price, pack options, lead time and documentation.